C
China Shineway Pharmaceutical Group Ltd
OTC:CSWYY
China Shineway Pharmaceutical Group Ltd
OTC:CSWYY
Price:
19.25
USD
Market Closed
Market Cap:
$727.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
China Shineway Pharmaceutical Group Ltd
OTC:CSWYY
|
CN |
|
Deswell Industries Inc
NASDAQ:DSWL
|
MO |
|
N
|
National Instruments Corp
F:NI1
|
US |
|
K
|
KeyMed Biosciences Inc
HKEX:2162
|
CN |
Income Statement
Earnings Waterfall
China Shineway Pharmaceutical Group Ltd
China Shineway Pharmaceutical Group Ltd
Income Statement
China Shineway Pharmaceutical Group Ltd
China Shineway Pharmaceutical Group Ltd
Currency: CNY
| Dec-2004 | Jun-2005 | Dec-2005 | Jun-2006 | Dec-2006 | Jun-2007 | Dec-2007 | Jun-2008 | Dec-2008 | Jun-2009 | Dec-2009 | Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
13
|
17
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
17
|
0
|
1
|
0
|
1
|
0
|
3
|
0
|
6
|
0
|
|
| Revenue |
704
N/A
|
739
+5%
|
831
+13%
|
878
+6%
|
842
-4%
|
885
+5%
|
1 013
+14%
|
1 194
+18%
|
1 275
+7%
|
1 341
+5%
|
1 633
+22%
|
1 862
+14%
|
2 038
+9%
|
2 151
+5%
|
1 985
-8%
|
1 939
-2%
|
2 132
+10%
|
2 189
+3%
|
2 187
0%
|
2 227
+2%
|
2 229
+0%
|
2 239
+0%
|
2 055
-8%
|
1 877
-9%
|
1 993
+6%
|
1 873
-6%
|
1 920
+2%
|
2 413
+26%
|
2 570
+7%
|
2 633
+2%
|
2 706
+3%
|
2 528
-7%
|
2 656
+5%
|
3 020
+14%
|
3 224
+7%
|
3 485
+8%
|
3 951
+13%
|
4 534
+15%
|
4 517
0%
|
4 205
-7%
|
3 778
-10%
|
3 344
-11%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(252)
|
(255)
|
(275)
|
(282)
|
(249)
|
(250)
|
(275)
|
(323)
|
(361)
|
(394)
|
(455)
|
(532)
|
(603)
|
(668)
|
(683)
|
(682)
|
(740)
|
(743)
|
(713)
|
(735)
|
(751)
|
(756)
|
(694)
|
(650)
|
(707)
|
(679)
|
(653)
|
(720)
|
(694)
|
(711)
|
(724)
|
(645)
|
(668)
|
(761)
|
(813)
|
(897)
|
(1 012)
|
(1 117)
|
(1 122)
|
(1 042)
|
(946)
|
(891)
|
|
| Gross Profit |
452
N/A
|
484
+7%
|
557
+15%
|
596
+7%
|
592
-1%
|
635
+7%
|
738
+16%
|
871
+18%
|
914
+5%
|
947
+4%
|
1 178
+24%
|
1 330
+13%
|
1 435
+8%
|
1 482
+3%
|
1 302
-12%
|
1 257
-3%
|
1 392
+11%
|
1 446
+4%
|
1 474
+2%
|
1 492
+1%
|
1 478
-1%
|
1 483
+0%
|
1 361
-8%
|
1 227
-10%
|
1 286
+5%
|
1 195
-7%
|
1 267
+6%
|
1 693
+34%
|
1 876
+11%
|
1 922
+2%
|
1 982
+3%
|
1 883
-5%
|
1 988
+6%
|
2 259
+14%
|
2 410
+7%
|
2 588
+7%
|
2 938
+14%
|
3 417
+16%
|
3 394
-1%
|
3 162
-7%
|
2 832
-10%
|
2 453
-13%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(171)
|
(182)
|
(214)
|
(237)
|
(250)
|
(228)
|
(312)
|
(315)
|
(339)
|
(342)
|
(466)
|
(517)
|
(491)
|
(478)
|
(418)
|
(537)
|
(668)
|
(679)
|
(699)
|
(707)
|
(722)
|
(732)
|
(663)
|
(682)
|
(698)
|
(671)
|
(780)
|
(1 167)
|
(1 343)
|
(1 336)
|
(1 419)
|
(1 377)
|
(1 473)
|
(1 672)
|
(1 774)
|
(1 931)
|
(2 111)
|
(2 340)
|
(2 261)
|
(1 912)
|
(1 818)
|
(1 638)
|
|
| Selling, General & Administrative |
(172)
|
(190)
|
(232)
|
(261)
|
(252)
|
(281)
|
(339)
|
(353)
|
(362)
|
(365)
|
(489)
|
(553)
|
(547)
|
(555)
|
(485)
|
(574)
|
(676)
|
(678)
|
(701)
|
(698)
|
(697)
|
(705)
|
(678)
|
(669)
|
(648)
|
(653)
|
(763)
|
(1 095)
|
(1 254)
|
(1 332)
|
(1 403)
|
(1 381)
|
(1 459)
|
(1 586)
|
(1 763)
|
(1 902)
|
(2 107)
|
(2 323)
|
(2 314)
|
(2 111)
|
(1 895)
|
(1 701)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(14)
|
(9)
|
(33)
|
(31)
|
(22)
|
(29)
|
(57)
|
(64)
|
(68)
|
(75)
|
(83)
|
(78)
|
(80)
|
(78)
|
(69)
|
(84)
|
(74)
|
(66)
|
(97)
|
(144)
|
(128)
|
(100)
|
(103)
|
(77)
|
(100)
|
(105)
|
(113)
|
(116)
|
(117)
|
(137)
|
(110)
|
(107)
|
(101)
|
(106)
|
|
| Other Operating Expenses |
1
|
7
|
18
|
25
|
2
|
53
|
27
|
38
|
37
|
32
|
57
|
67
|
78
|
107
|
124
|
100
|
76
|
73
|
86
|
70
|
55
|
50
|
84
|
71
|
24
|
48
|
79
|
71
|
39
|
96
|
86
|
82
|
86
|
19
|
102
|
87
|
113
|
120
|
163
|
305
|
178
|
169
|
|
| Operating Income |
281
N/A
|
302
+7%
|
343
+14%
|
360
+5%
|
342
-5%
|
407
+19%
|
426
+5%
|
556
+31%
|
575
+3%
|
605
+5%
|
713
+18%
|
813
+14%
|
944
+16%
|
1 005
+6%
|
884
-12%
|
719
-19%
|
724
+1%
|
767
+6%
|
776
+1%
|
785
+1%
|
756
-4%
|
751
-1%
|
698
-7%
|
545
-22%
|
588
+8%
|
524
-11%
|
487
-7%
|
525
+8%
|
533
+1%
|
586
+10%
|
562
-4%
|
506
-10%
|
515
+2%
|
587
+14%
|
637
+8%
|
657
+3%
|
827
+26%
|
1 078
+30%
|
1 133
+5%
|
1 250
+10%
|
1 014
-19%
|
815
-20%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
45
|
16
|
150
|
103
|
(99)
|
21
|
172
|
103
|
48
|
54
|
66
|
82
|
76
|
72
|
86
|
100
|
125
|
104
|
99
|
108
|
107
|
98
|
101
|
125
|
136
|
114
|
125
|
134
|
114
|
104
|
100
|
104
|
90
|
99
|
109
|
183
|
128
|
236
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(45)
|
(45)
|
(234)
|
(217)
|
(16)
|
(10)
|
0
|
0
|
(2)
|
(2)
|
4
|
8
|
|
| Total Other Income |
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
281
N/A
|
302
+7%
|
343
+14%
|
360
+5%
|
387
+8%
|
423
+9%
|
576
+36%
|
660
+15%
|
476
-28%
|
626
+31%
|
884
+41%
|
916
+4%
|
992
+8%
|
1 058
+7%
|
950
-10%
|
802
-16%
|
800
0%
|
839
+5%
|
860
+3%
|
885
+3%
|
864
-2%
|
855
-1%
|
797
-7%
|
653
-18%
|
695
+7%
|
622
-11%
|
588
-6%
|
650
+11%
|
669
+3%
|
700
+5%
|
643
-8%
|
595
-7%
|
395
-34%
|
474
+20%
|
720
+52%
|
751
+4%
|
917
+22%
|
1 177
+28%
|
1 240
+5%
|
1 431
+15%
|
1 146
-20%
|
1 058
-8%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(11)
|
(8)
|
(5)
|
(26)
|
(54)
|
(65)
|
(85)
|
(99)
|
(78)
|
(95)
|
(117)
|
(129)
|
(170)
|
(219)
|
(194)
|
(130)
|
(152)
|
(161)
|
(176)
|
(182)
|
(159)
|
(169)
|
(139)
|
(104)
|
(106)
|
(126)
|
(136)
|
(125)
|
(163)
|
(164)
|
(140)
|
(125)
|
(100)
|
(124)
|
(163)
|
(172)
|
(194)
|
(294)
|
(271)
|
(327)
|
(306)
|
(230)
|
|
| Income from Continuing Operations |
270
|
293
|
337
|
334
|
333
|
358
|
491
|
561
|
398
|
531
|
767
|
787
|
822
|
840
|
756
|
672
|
648
|
678
|
684
|
703
|
705
|
685
|
658
|
549
|
589
|
496
|
452
|
526
|
506
|
537
|
503
|
469
|
295
|
350
|
557
|
579
|
723
|
883
|
970
|
1 105
|
840
|
828
|
|
| Income to Minority Interest |
(9)
|
(8)
|
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
261
N/A
|
286
+9%
|
332
+16%
|
334
+1%
|
333
0%
|
358
+8%
|
491
+37%
|
561
+14%
|
398
-29%
|
531
+33%
|
767
+44%
|
787
+3%
|
822
+4%
|
840
+2%
|
756
-10%
|
672
-11%
|
648
-4%
|
678
+5%
|
684
+1%
|
703
+3%
|
705
+0%
|
685
-3%
|
658
-4%
|
549
-17%
|
589
+7%
|
496
-16%
|
452
-9%
|
526
+16%
|
506
-4%
|
537
+6%
|
503
-6%
|
469
-7%
|
295
-37%
|
350
+19%
|
557
+59%
|
579
+4%
|
723
+25%
|
883
+22%
|
970
+10%
|
1 105
+14%
|
840
-24%
|
828
-1%
|
|
| EPS (Diluted) |
0.42
N/A
|
0.34
-19%
|
0.4
+18%
|
0.4
N/A
|
0.4
N/A
|
0.43
+7%
|
0.59
+37%
|
0.67
+14%
|
0.48
-28%
|
0.65
+35%
|
0.93
+43%
|
0.95
+2%
|
0.99
+4%
|
1.01
+2%
|
0.91
-10%
|
0.81
-11%
|
0.78
-4%
|
0.82
+5%
|
0.83
+1%
|
0.85
+2%
|
0.85
N/A
|
0.83
-2%
|
0.8
-4%
|
0.66
-18%
|
0.71
+8%
|
0.6
-15%
|
0.55
-8%
|
0.64
+16%
|
0.62
-3%
|
0.67
+8%
|
0.64
-4%
|
0.61
-5%
|
0.39
-36%
|
0.46
+18%
|
0.74
+61%
|
0.77
+4%
|
0.96
+25%
|
1.17
+22%
|
1.28
+9%
|
1.46
+14%
|
1.11
-24%
|
1.1
-1%
|
|
Switch to:
Switch to:
See Also
Discover More
